How do you pay?

How to pay the least

Ask for the cash price

Cabenuva

We didn’t find one.

  1. Ask your pharmacy for Cabenuva’s cash price, and one or two other pharmacies too.
  2. Cabenuva’s savings card works only with insurance from a job or one you bought.

Free from the maker, if you qualify ViiV Healthcare Patient Assistance Program (PAP). Patients whose income exceeds program eligibility maximum will be provided the opportunity to demonstrate that their eligible medical expenses bring them within the income eligibility criteria (please contact program for details). Or call 1-844-588-3288.

See if you qualify 

Compare every option

Question
Brand nameCabenuva
Authorized genericcabotegravir and rilpivirine
Regular genericcabotegravir and rilpivirine
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone found
Same as Cabenuva?
The original
–
–

Brand nameThe maker’s card

ViiVConnect Copay Program (CABENUVA Savings Program)

Savings card from ViiV Healthcare

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a fill

The card takes up to $13,000 a year off your co-pay.

Sign up on viivconnect.com 

Or call 1-844-588-3288.

In the maker’s words

“Eligible Patients may pay as little as $0 on each prescription fill…”

From the maker’s offer on viivconnect.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Cabenuva itself, from the same company, sold without the brand name, and usually for less. For now Cabenuva is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

We didn’t find one. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

CABENUVA, a 2-drug co-packaged product of cabotegravir, an HIV-1 integrase strand transfer inhibitor (INSTI), and rilpivirine, an HIV-1 non‑nucleoside reverse transcriptase inhibitor (NNRTI), is indicated as a complete regimen for the treatment of HIV-1 infection in adults and adolescents 12 years of age and older and weighing at least 35 kg to replace the current antiretroviral regimen in those who are virologically suppressed (HIV‑1 RNA <50 copies/mL) on a stable antiretroviral regimen with no history of treatment failure and with no known or suspected resistance to either cabotegravir or rilpivirine.

Source: the FDA label for Cabenuva (ViiV Healthcare Company), November 26, 2025. Full label on DailyMed 

Good to know